- Nachrichtendetail
-
07.05.2024 17:09:51 - dpa-AFX: *FDA ADVISORY COMMITTEE TO REVIEW ELI LILLY'S DONANEMAB FOR EARLY ALZHEIMER'S TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ELI LILLY | 858560 | Xetra | 741,900 | 23.05.24 13:40:30 | +5,200 | +0,71% | 741,500 | 741,900 | 744,000 | 736,700 |
